ABSTRACT
INTRODUCTION
Microarray technologies are increasingly used to detect differential gene expression between two conditions (for example, time points). It is challenging to analyze such large amounts of data. Specifically, for each of the thousands of genes on the array, we want to make statistical inference whether its expression levels have changed from condition one to condition two. Note that this goal requires more than a global test for determining whether there are any differentially expressed genes (Allison et al., 2002) . We want to identify those genes with differential expression. In the context of statistical hypothesis testing, the problem can be formulated as testing a null hypothesis H 0 that there is no differential expression for each gene. Then a test statistic Z can be constructed for each gene. A key is how to determine a reference distribution, e.g. the null distribution (i.e. the distribution under H 0 ), for Z such that a cut-off point can be determined to claim significance for genes whose Z (or |Z |) exceed the cut-off point. Many classic statistical tests (e.g. t-test and Wilcoxon's test) and new methods (e.g. Baldi and Long, 2001; Broet et al., 2002; Chen et al., 1997; Dudoit et al., 2002; Kerr et al., 2000; Kooperberg et al., 2002; Lee et al., 2002; Li and Wong, 2001; Li et al., 2002; Newton et al., 2001 Newton et al., , 2003 Pan et al., 2002a; Strand et al., 2002; Thomas et al., 2001) have been proposed; for two recent reviews, see Pan (2002a) and Smyth et al. (2002) . Among many new methods, a class of nonparametric statistical methods, including the empirical Bayes (EB) method of Efron et al. (2000 Efron et al. ( , 2001 , the significance analysis of microarray (SAM) method of Tusher et al. (2001) and the mixture model method (MMM) of Pan et al. (2001) , have many attractive properties when applied to replicated microarray experiments. This class of nonparametric methods are very powerful because they do not depend on strong parametric assumptions, and at the same time they take advantage of the special feature of microarray data; that is, there are a large number of genes to be tested whereas the number of replicates is usually small. The basic idea is to estimate a reference (e.g. null) distribution of a test statistic Z by constructing a corresponding so-called null statistic z. Based on the given data and thus constructed z for each gene, one can estimate the distribution (or more generally, some of its characteristics) of z. The distribution of z is then used to approximate the reference distribution such that statistical inference can be accomplished by using Z and its estimated reference distribution. Currently the most popular way of constructing z is to take it as a permutational version of Z , similar to the idea in permutation tests. This idea is general and has been used elsewhere (Xu et al., 2002) . Intuitively, the performance of such a method more or less depends on how well the distribution of z approximates the null distribution of Z . The goal of this study is several folds. First, we point out some problems with the existing method of constructing Z and z, and propose a new method that works better in estimating the null distribution of the test statistic. Second, we assess and compare the performance of each of the two methods of constructing test/null statistics in the context of EB, SAM and MMM. We also report on some interesting findings on the operating characteristics of EB, SAM and MMM. Finally, based on the findings on the performance of SAM and MMM, we outline a simple nonparametric method that aims to estimate the total number of significant genes and the false positive number by direct use of the test/null statistics. In particular, it does not involve estimating any complex distributional characteristics (e.g. the expected order statistics in SAM and the full distribution in MMM).
A CURRENT METHOD
For the purpose of presentation here, we can restrict our attention to looking at a single gene. The idea easily extends to more than one gene, as to be shown in the results section.
Suppose that the observed expression levels of a given gene under two conditions are (X 1 , . . . , X n 1 ) and (Y 1 , . . . , Y n 2 ) with the corresponding means as µ 1 and µ 2 respectively. The null hypothesis to be tested is H 0 : µ 1 = µ 2 . A commonly used test statistic is the two-sample equal-variance t-statistic (Dudoit et al., 2002; Pan, 2002a) applied to the two samples (X 1 , . . . , X n 1 ) and (Y 1 , . . . , Y n 2 ):
i=1 Y i /n 2 are the sample means, and s 2 is the pooled sample variance ). Then z is the same two-sample equal-variance t-statistic applied to the above permuted two samples.
In Efron et al. (2001) and Tusher et al. (2001) , it is suggested to add a small constant number s 0 in the denominator to avoid that a close-to-zero denominator of Z or z leads to much inflated Z or z. This treatment seems to be reasonable for practical purposes and can have better performance than the usual t-statistic Lonnstedt and Speed (2002) , but unfortunately hampers a tractable analysis: for example, even under the normality assumption, the statistic no longer simply has a t distribution. Thus, in the following, we use the usual t-statistic.
In EB, SAM and MMM, it is assumed that under H 0 , the Z statistics of all the genes have the same distribution, leading to the use of the z statistics of all the genes to estimate a reference distribution for Z . As usual, this assumption may or may not hold in practice. Nevertheless, at least, this assumption is weaker than that of the t-test. Even if the expression levels of different genes are from different distributions, if these distributions belong to the same member of a location-scale family (Lehmann, 1983, p. 21 ) (which includes the normal distribution required by the t-test), then the assumption holds. A referee also suggests that, rather than assuming this for all genes, one can partition genes into several groups based on their expression levels and then assume that the assumption holds within each group.
Under H 0 , if all the genes have no differential expression, then the permutational distribution of Z (i.e. the distribution of the null statistic z) provides a good approximation to the null distribution of Z . However, with gene expression data, unlike in other traditional permutation tests such as the Wilcoxon test and a permutation-based t-test (e.g. Dudoit et al., 2002) , here we are testing multiple H 0 for many genes and the permutational distribution of a statistic is pooled over all genes. In practice, because for real data we usually have genes with differential expression, then the distribution of z is a mixture of the (estimated) null distribution of Z (for genes with no differential expression) and a permutational distribution of Z for genes with differential expression with the latter introducing extra variation. Hence, using the null statistic z may not estimate the null distribution of Z well, especially when there is a relatively large proportion of genes with differential expression and/or the magnitude of their expression change is large. It is possible that in SAM or MMM, statistical inference can be accomplished using the permutational distribution of Z , as in other permutationbased tests. However, because the permutational distribution of Z can be more dispersed than the null distribution of Z (as to be verified later), use of the former can lead to reduced statistical power. Furthermore, strictly speaking, the EB approach requires the estimation (or use) of the null distribution of Z . Therefore, it seems reasonable to expect that the performance of EB, SAM and MMM can be improved if the null distribution of the test statistic can be better estimated.
There is also a minor problem with the use of the twosample equal-variance t-statistic Z . If the two samples have unequal variances, then using the pooled sample variance leads to a biased estimator of the standard error of the numerator. This can be fixed simply by using the two-sample unequal-variance t-statistic.
An alternative method of constructing a test statistic and a null statistic was proposed in Pan et al. (2001) . Zhao and Pan (2002) pointed out its weakness and proposed two modifications, which however may have low efficiency because of their reduced degrees of freedom in estimating the variances, (n 1 + n 2 )/2 − 2 and max(n 1 , n 2 ) − 2 respectively. Our proposal next follows the same line and has the degrees of freedom larger in estimating the variances (i.e. n 1 + n 2 − 4).
A NEW METHOD
The motivation is to adopt a t-statistic or its modification as a test statistic such that a null statistic can be constructed to approximate the null distribution of the test statistic. In particular, because the mean of the numerator of a t-statistic under H 0 is always 0, we want the mean of the numerator of the null statistic is always 0, no matter whether H 0 holds or not. For this purpose, we partition each of the two samples into two (almost) equally-sized parts. For k = 1, 2, define n k2 = n k1 if n k = 2n k1 , and n k2 = n k1 + 1 if n k = 2n k1 + 1. Then, our proposed test statistic is 
j=1 X j /n 11 ) 2 /(n 11 − 1), and similarly for the other three. The null statistic is 
As a referee pointed out, z1 corresponds to Z 1 applied to a specific permutation of the two samples. A striking feature is that the numerator of z1 are the sum of the two within-sample differences, leading to that the mean of the numerator of z1 is always 0, the same as that of Z 1 under H 0 . The construction of the denominator of Z 1 or z1 is motivated such that the denominator is independent of the numerator, at least, under the Normality assumption for X i and Y i . Note that the denominators of Z 1 and z1 have the same form. Hence, it seems reasonable to expect that z1 can serve to approximate the null distribution of Z 1.
Before constructing Z or z1, one can randomly permute the two samples X 's and Y 's separately. In particular, in this way, we can obtain multiple (e.g. 50) sets of z1 from permuted data.
Note that Z 1 is different from and less efficient than the usual two-sample unequal-variance t-statistic that is used in Pan et al. (2001) , but the efficiency loss is small. For instance, in the denominatorof Z 1, the degrees of freedom used to estimate the variances in Z 1 are n 1 + n 2 − 4, compared with the slightly larger n 1 + n 2 − 2 in the t-statistic. Compared with the two modifications in Zhao and Pan (2002) , the current proposal is much more efficient. However, a merit of their second modification is that it does not require the distribution of random errors to be symmetric, whereas it is required here.
RESULTS
Using simulated and real data, we compare the performance of the two methods of constructing the test and null statistics in SAM, MMM and EB. Along the way, we also compare the performance of SAM, MMM and EB with each other.
Simulated data
We consider G = 500 + 500 genes, the first 500 with no differential expression and the next 500 with differential expression. We assume, for genes g = 1, . . . , 500,
all the random variables are independent with each other. There are n 1 = n 2 = 4 arrays under each condition.
For a randomly simulated data set with 1000 X 's and Y 's, for each of 1000 genes, we calculated its Z or Z 1, and B = 50 sets of z or z1 with randomly permuted data. Note that in the above simulation set-up, the true null distributions of Z and Z 1 are respectively the Student's tdistribution with degrees of freedom n − 2 = 6 (t 6 ) and that with degrees of freedom n − 4 = 4 (t 4 ). Hence we randomly generated 1000 z 0 and z1 0 respectively from the true null distributions of Z and Z 1 (i.e. t 6 and t 4 ). Then each of the following statistics can be applied to SAM and MMM: (1) the current (Z , z); (2) the proposed new (Z 1, z1); (3) the current Z and its 'true' null statistic z 0 ; (4) the new Z 1 and its 'true' null statistic z1 0 .
Comparison of the (null) distributions
First we compare the density function of each null statistic with the true null density function; for details, see Pan (2002b) . A finite Normal mixture model was fitted to ten permuted sets of each null statistic to estimate its density function. It turns out that, as expected, the density estimate of z is in disagreement from the true null density with the former having heavier tails; the sample variance of z is 5.9, quite different from 1.5, the variance of the true null distribution. In contrast, the density estimate of z1 matches the true null density very well. The sample variance of z1 is 1.9, compared with 2.0 of the true null distribution. Unsurprisingly, each estimated density for the 'true' null statistic z 0 or z1 0 is in agreement with the corresponding true density function.
Note that by the simulation set-up we know that the first 500 genes do not have differential expression, hence the distribution of their test statistics Z or Z 1 is the true null distribution. The same conclusion as above was reached when the two sample Kolmogorov-Smirnov test was applied to compare the distribution of each null statistic to the distribution of the test statistic for the first 500 genes. Table 1 shows the identified numbers of significant genes (i.e. estimated total positives, T P), the estimated numbers of false positives ( F P), and the true numbers of false positives (F P) for each of the four EB, SAM or MMM implementations with various threshold values. In EB, the threshold used is τ , the (posterior) odds of having differential expression for a gene. In SAM, it is d, a parameter used to control the FP. MMM uses the traditional significance level (i.e. Type I error rate) α. In MMM, rather than using the more efficient but complex likelihood ratio test, we define the rejection region as the two tails, e.g. |Z | > A = A(α; z), such that the tail probability under the (estimated) distribution of the null statistic (e.g. z) is equal to α Pan et al. (2002b) . Also for MMM, as in SAM, the null statistics were used to obtain F P: F P is the average number of, e.g. z's, falling into the rejection region (i.e. satisfying |z| > A) in each permuted set of z. Note that the true number of total positives is always 500.
Identifying significant genes
There is a conceptual difficulty when we compare F P with the true FP. In the original proposal of SAM, F P is obtained based on testing all (i.e. 1000) genes. However, when we calculate the true FP, it is based on testing the first 500 genes without differential expression. Hence, if an estimation procedure works perfectly, we will have F P=2FP. To facilitate comparison, in the sequel for the simulated data, the use of F P in any method refer to that obtained from testing 500 genes; in other words, an adjustment is done by dividing a F P that is obtained from testing 1000 genes by a factor of 2 to give a new F P that can be compared with the true FP. This adjustment is directly related to the formula of estimating the FDR as p 0 F P/ T P, given in Efron et al. (2001) , with p 0 as the prior probability of having equivalent expression. In our case, p 0 = 500/1000 = 1/2, and thus F D R = F P/ T P.
For each of the four versions of SAM, we can see that using various null statistics yields similar T P. This is somewhat surprising. Recall that we have shown that the distribution of z is different from the null distribution of Z , whereas the distribution of z1 is much closer to the null distribution of Z 1. However, the performance difference of using z or z1 to estimate the null distribution seems to have no obvious effect on the ultimate performance of SAM in identifying significant genes. This is a desirable robustness property of SAM, though as always, the robustness can be only up to certain extent (Pan, 2002b) . For instance, if we take d = 25, using z or z 0 in SAM will lead to 0 or 10 detected significant genes respectively. For MMM, as analyzed earlier, using z to estimate the null distribution of Z leads to conservative inference when compared with using (Z 1, z1): use of z may yield smaller numbers of total positives T P and over-estimate numbers of false positives (i.e. F P F P), whereas the corresponding performance of using z1 is much better. A comparison using a receiving operating characteristic (ROC) plot is shown in Figure 1 . As usual, the sensitivity is estimated by T P/500, but for our purpose, we use F P/500 to estimate α = 1−specificity. It can be seen that for small α, which is more often of interest, MMM(Z 1, z1) has a much higher sensitivity or power than MMM(Z , z). For instance, as shown in Table 1 , for α = 1/500, MMM(Z 1, z1) correctly detects 270 differentially expressed genes, almost ten times of that (i.e. 28) from MMM(Z , z). In addition, when the significance level α is very small, unsurprisingly, use of the estimated null statistic z results in loss of power when compared with using the 'true' null statistic z 0 . The results from using z 0 or z1 0 are close to those (not shown) from using the corresponding t-test.
In EB, ten sets of the null statistics were used to fit a nonparametric logistic regression model using the Splus function gam() with default smoothing parameter values. A gene is claimed to be significant if its estimated (posterior) odds of having differential expression are larger than τ . As in SAM and MMM, the null statistics Table 1 . Results of SAM, MMM and EB by using various statistics for simulated data were used to obtain F P: F P is the average number of, e.g. z's, with the estimated odds greater than τ . Note that because the threshold τ is interpreted as odds, it is valid to compare the four implementations of EB using the same value of τ . It can be seen that, unless τ is very large, surprisingly, use of (Z , z) does not show obvious conservativeness when compared with the use of (Z 1, z1). In fact, when τ is as small as 1, the inference based on (Z , z) is more liberal than (Z 1, z1). Similarly, it is surprising that in most cases EB(Z , z 0 ) is not a clear winner over EB(Z 1, z1 0 ) because z 0 with larger degrees of freedom is less dispersed than z1 0 . An explanation is given below. In EB, the (prior) probability (or proportion) p 1 of genes with differential expression has to be estimated, and the final estimated (posterior) odds are monotonically increasing with p 1 . However, in a nonparametric setting, p 1 is not estimable. Efron et al. (2001) give a lower bound of it as its estimate, which may confound the performance. The estimated p 1 in EB(Z , z), EB(Z 1, z1), EB(Z , z 0 ) and EB(Z 1, z1 0 ) are 0.458, 0.393, 0.345 and 0.389 respectively. Hence, the fact that 0.458 > 0.393 and 0.389 > 0.345 leads to a possibly higher statistical power of EB(Z , z) than EB(Z 1, z1) and that of EB(Z 1, z1 0 ) than EB(Z , z 0 ) for some τ . Nevertheless, as threshold τ increases, the conservativeness of EB(Z , z) when compared with EB(Z 1, z1) will finally show up.
Other comparisons
Similar results were obtained on other two independently simulated data sets. A comparison was also conducted with the t-test and with a parametric Bayes approach (Kendziorski et al., 2002) . Due to the limited space, we do not show the results, which are available in Pan (2002b) .
Real data
Now we apply the methods to the leukemia data of Golub et al. (1999) . The biological samples of two subtypes of the cancer, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), were compared. The data were obtained from Affymetrix arrays containing G = 7129 genes. To facilitate the comparison with earlier results (Pan, 2002a) , we used the same n 1 = 26 ALL and n 2 = 10 AML samples, and the same data preprocessing method as in Pan (2002a) . Table 2 presents the number of significant genes identified by MMM when the two methods of constructing Pan, 2002b) . Taking the gene-specific significance level α = 0.01/7129, we compare the number of significant genes obtained here with that from earlier studies. MMM(Z , z) and MMM(Z 1, z1) detected 55 and 50 significant genes respectively. In Pan (2002a) , MMM found 187 genes, which however may be too liberal because of possibly inflated false positive rate resulting from the problematic method of constructing the test and null statistics there (Zhao and Pan, 2002) . Using a modified method of constructing the test and null statistics in MMM, Zhao and Pan (2002) identified 58 genes, comparable to the results here. The regression approach of Thomas et al. (2001) listed 187 genes (Pan, 2002a) , which is likely to be too liberal due to the questionable use of the large-sample normal approximation to the null distribution. On the other hand, in agreement with the simulation study in Zhao and Pan (2002) , the t-test can be very conservative when the Normality assumption on the gene expression levels is not satisfied: Using the test statistic Z , the t-test with degrees of freedom 22 and the Welch t-test (Pan, 2002a) both found only 20 genes. Of course, ideally, biological studies are needed to validate these results.
Remarks
A new simple method to detect differential gene expression. It is possible to combine the ideas of SAM, MMM and EB to obtain a simple and robust nonparametric method as follows. Suppose that we have constructed a test statistic Z and a null statistic z (or its multiple realizations) for each gene. Without loss of generality, we assume that an extreme value of |Z | of a gene provides evidence against a null hypothesis H 0 for the corresponding gene. Following the idea of SAM and MMM, for any given positive threshold value A, we can estimate the TP and FP as: T P = #{Z : |Z | > A} and F P = Ave. #{z : |z| > A}. That is, the rejection region is the two tails of the distribution of Z , and T P and F P are respectively the (average) numbers of Z and of z falling into the rejection region. Of course, the method can be generalized to using two different values A 1 and A 2 for two tails, which, for example, can be formalized as using the likelihood ratio test as proposed in MMM (Pan et al., 2001) . Then, as in SAM, by trying various threshold values A, one can choose one based on the desired T P and F P (or their ratio, F D R). The most striking advantage of this method is its simplicity. A close variant of this method has been used in a regression model for time course gene expression data (Xu et al., 2002) .
More on SAM. In our implementation, we have not added a small number s 0 in the denominator of the t-statistic, which is a part of the original SAM implementation . Applying the original SAM software to the simulated data, we obtained s 0 = 1.373. By adding this s 0 = 1.373 to the denominator of each Z and z, we obtained the following results: (1) when d = 1, we have that T P = 328, F P = 9.97 and true F P = 0; (2) when d = 0.3, we have that T P = 444, F P = 91.18 and true F P = 27; and (3) when d = 0.2, we have that T P = 529, F P = 138.71 and true F P = 91. These results are almost the same as those obtained from using the original SAM software.
DISCUSSION
We have pointed out some problems with an existing permutation method to construct null statistics. A key point is that, with real data where some genes are indeed differentially expressed (or more generally, the null hypothesis to be tested does not hold for some genes), the naive application of a test statistic to permuted data may not lead to good estimation of the null distribution of the test statistic: usually, such a distribution based on the permutation is more dispersed than the null distribution, resulting in more conservative inference with reduced statistical power (i.e. a smaller number of identified significant genes) or over-estimation of the number of false positives. Note that such use of permutation to draw inference is not only applicable in EB, SAM and MMM, but also proposed to be used in other recently developed statistical methods, such as a parametric regression model for microarray time course data (Xu et al., 2002) . Our results have important implications on all these permutation-based methods.
In the context of detecting differentially expressed genes under two conditions, we have proposed a new method to construct the null statistic z1 that can estimate the null distribution of the test statistic Z 1 better, thus leading to better inferential procedures. Using simulated data, these points have been confirmed. However, for the leukemia data, use of the new statistics does not lead to much different results. The key lies in when the existing permutation-based method cannot work well. When the proportion of the genes with differential expression is large, as is the case with our simulated data or with some customized cDNA arrays, the permutational distribution of the test statistic (i.e. that of z) may not approximate the null distribution of the test statistic well. Otherwise, the permutational distribution can still provide a good approximation, as is the case with the leukemia data or with many of today's general-purpose arrays.
A limitation of using (Z 1, z1) is that at least 4 arrays are required under each condition whereas only 2 arrays are required for (Z , z) . Also, the new statistics (Z 1, z1) are specifically designed for two-sample comparison. Whether the method can be extended to other contexts, such as with survival data or longitudinal data (Guo et al., 2003) , is not clear.
Our study also led to some interesting findings on the behavior of EB, SAM and MMM. SAM is more robust to the use of the null statistic than MMM is. In this work we studied a method, similar to that in SAM, to estimate the number of false positives (and thus FDR) in EB and MMM. The performance assessment on the estimation of total positives and false positives in EB is confounded by conservatively estimating the prior probability of having differential expression by its lower bound, but a numerical comparison with a parametric EB (Pan, 2002b) showed the competitiveness of EB, at least based on a simulated data set. Finally, by summarizing the shared basic idea of SAM, MMM and EB, we have proposed a simple method to detect differential gene expression. It is worthwhile in future studies to further evaluate the method.
